NOTA:FRA
Novartis AG
125,00 €
0,00%
(0,00) 1 p
28. sept, 22:00:00 GMT +2 · EUR
search
Kõik sümbolid
1 p
5 p
1 kuu
6 kuud
YTD
1 a
5 a
MAX
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse NOTA põhistatistika genereerimine…
Ava
125,00 €
Kõrge
125,00 €
Madal
125,00 €
Turu kapit.
297,21Â mld
Keskm. maht
26,00
Maht
0,00
52 näd kõrgeim
145,00 €
52 näd madalaim
102,50 €
Töötajate arv
75Â tuh
Ava
125,00 €
Kõrge
125,00 €
Madal
125,00 €
Turu kapit.
297,21Â mld
Keskm. maht
26,00
Maht
0,00
52 näd kõrgeim
145,00 €
52 näd madalaim
102,50 €
Töötajate arv
75Â tuh
Uudised
Veebiallikatest ja uudistepartneritelt
AD HOC NEWS
·
8 tunni eest
Novartis stock at CHF 121.22 on September 28, 2026
AD HOC NEWS
·
20 tunni eest
Novartis stock gets a higher FY2027 EPS forecast
Profiil
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Teave üksuse Novartis AG kohta
TegevjuhtVasant Narasimhan
Töötajad75,3 tuh
Asutatud7. märts 1996
PeakontoridBasel, Basel, Å veits
Sektor-
Veebisaitnovartis.com